These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12674754)

  • 21. HDL3-mediated inactivation of LDL-associated phospholipid hydroperoxides is determined by the redox status of apolipoprotein A-I and HDL particle surface lipid rigidity: relevance to inflammation and atherogenesis.
    Zerrad-Saadi A; Therond P; Chantepie S; Couturier M; Rye KA; Chapman MJ; Kontush A
    Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2169-75. PubMed ID: 19762782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative effects of purified apolipoproteins A-I, A-II, and A-IV on cholesteryl ester transfer protein activity.
    Guyard-Dangremont V; Lagrost L; Gambert P
    J Lipid Res; 1994 Jun; 35(6):982-92. PubMed ID: 8077854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory effects of HepG2 cell-derived apolipoprotein A-I-containing lipoproteins on cholesteryl ester accumulation in macrophages.
    Kawano T; Hakamata H; Ohta T; Ding Y; Yoshida M; Ueda S; Horiuchi S
    Biochemistry; 1997 Aug; 36(32):9816-25. PubMed ID: 9245414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macrophage apoAI protects against dyslipidemia-induced dermatitis and atherosclerosis without affecting HDL.
    Tavori H; Su YR; Yancey PG; Giunzioni I; Wilhelm AJ; Blakemore JL; Zabalawi M; Linton MF; Sorci-Thomas MG; Fazio S
    J Lipid Res; 2015 Mar; 56(3):635-643. PubMed ID: 25593328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased apolipoprotein AI production rate and redistribution of high-density lipoprotein size induced by estrogen plus progestin as oral contraceptive.
    Duvillard L; Dautin G; Florentin E; Jeannin A; Pais de Barros JP; Lagrost L; Petit JM; Gambert P; Vergès B
    J Clin Endocrinol Metab; 2009 Dec; 94(12):4891-7. PubMed ID: 19858317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of high density lipoprotein subfractions on endothelial eicosanoid secretion.
    Oravec S; Demuth K; Myara I; Hornych A
    Thromb Res; 1998 Oct; 92(2):65-71. PubMed ID: 9792113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipoprotein modulation of proteinuric renal injury.
    Tsuchida Y; Zhong J; Otsuka T; Dikalova A; Pastan I; Anantharamaiah GM; Linton MF; Yancey PG; Ikizler TA; Fogo AB; Yang H; Kon V
    Lab Invest; 2019 Jul; 99(8):1107-1116. PubMed ID: 31019291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for a paraoxonase-independent inhibition of low-density lipoprotein oxidation by high-density lipoprotein.
    Graham A; Hassall DG; Rafique S; Owen JS
    Atherosclerosis; 1997 Dec; 135(2):193-204. PubMed ID: 9430369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-density lipoprotein particle uptake and selective uptake of high-density lipoprotein-associated cholesteryl esters by J774 macrophages.
    Rinninger F; Greten H
    Biochim Biophys Acta; 1990 Apr; 1043(3):318-26. PubMed ID: 2157492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pegylation of high-density lipoprotein decreases plasma clearance and enhances antiatherogenic activity.
    Murphy AJ; Funt S; Gorman D; Tall AR; Wang N
    Circ Res; 2013 Jun; 113(1):e1-e9. PubMed ID: 23613182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of human native low-density and high-density lipoproteins on prostaglandin production by mouse macrophage cell line P388D1: possible implications in pathogenesis of atherosclerosis.
    Jambou D; Dejour N; Bayer P; Poirée JC; Frédenrich A; Issa-Sayegh M; Adjovi-Desouza M; Lapalus P; Harter M
    Biochim Biophys Acta; 1993 May; 1168(1):115-21. PubMed ID: 8504137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ezetimibe decreases serum amyloid A levels in HDL3 in hemodialysis patients.
    Hirano T; Nohtomi K; Nakanishi N; Watanabe T; Hyodo T; Taira T
    Clin Nephrol; 2010 Oct; 74(4):282-7. PubMed ID: 20875380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxidation of high-density lipoprotein HDL3 leads to exposure of apo-AI and apo-AII epitopes and to formation of aldehyde protein adducts, and influences binding of oxidized low-density lipoprotein to type I and type III collagen in vitro1.
    Greilberger J; Jürgens G
    Biochem J; 1998 Apr; 331 ( Pt 1)(Pt 1):185-91. PubMed ID: 9512478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apolipoprotein AIMilano. Disulfide-linked dimers increase high density lipoprotein stability and hinder particle interconversion in carrier plasma.
    Franceschini G; Calabresi L; Tosi C; Gianfranceschi G; Sirtori CR; Nichols AV
    J Biol Chem; 1990 Jul; 265(21):12224-31. PubMed ID: 2115514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simvastatin, an HMG-CoA reductase inhibitor, induces the synthesis and secretion of apolipoprotein AI in HepG2 cells and primary hamster hepatocytes.
    Bonn V; Cheung RC; Chen B; Taghibiglou C; Van Iderstine SC; Adeli K
    Atherosclerosis; 2002 Jul; 163(1):59-68. PubMed ID: 12048122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphatidylcholine and phosphatidylethanolamine plasmalogens in lipid loaded human macrophages.
    Wallner S; Orsó E; Grandl M; Konovalova T; Liebisch G; Schmitz G
    PLoS One; 2018; 13(10):e0205706. PubMed ID: 30308051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxidation of high density lipoproteins. II. Evidence for direct reduction of lipid hydroperoxides by methionine residues of apolipoproteins AI and AII.
    Garner B; Waldeck AR; Witting PK; Rye KA; Stocker R
    J Biol Chem; 1998 Mar; 273(11):6088-95. PubMed ID: 9497326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High density lipoproteins stimulate molecular weight 80K protein phosphorylation in human trophoblast cells: evidence for a protein kinase-C-dependent pathway in human placental lactogen release.
    Wu YQ; Handwerger S
    Endocrinology; 1992 Dec; 131(6):2935-40. PubMed ID: 1332852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel compound inhibits reconstituted high-density lipoprotein assembly and blocks nascent high-density lipoprotein biogenesis downstream of apolipoprotein AI binding to ATP-binding cassette transporter A1-expressing cells.
    Lyssenko NN; Brubaker G; Smith BD; Smith JD
    Arterioscler Thromb Vasc Biol; 2011 Nov; 31(11):2700-6. PubMed ID: 21836073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Production of cholesterol-enriched nascent high density lipoproteins by human monocyte-derived macrophages is a mechanism that contributes to macrophage cholesterol efflux.
    Kruth HS; Skarlatos SI; Gaynor PM; Gamble W
    J Biol Chem; 1994 Sep; 269(39):24511-8. PubMed ID: 7929116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.